NEXELIS Trademark

Trademark Overview

On Saturday, April 6, 2019, a trademark application was filed for NEXELIS with the United States Patent and Trademark Office. The USPTO has given the NEXELIS trademark a serial number of 88374397. The federal status of this trademark filing is REGISTERED as of Tuesday, October 26, 2021. This trademark is owned by Neomed Laboratory Topco Inc.. The NEXELIS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical, scientific and research laboratory services in preclinical and clinical immunology, immunogenicity, virology, bacteriology, immuno-oncology, biomarkers, vaccines, biologics, and immuno-therapeutics, immunochemistry assays, immunity assays, immunohistochemistry, histo-pathology, ligand binding assays, immuno-PCR, molecular assays, biomarkers, production of protein and immunologic reagents; conducting clinical trials for others
nexelis

General Information

Serial Number88374397
Word MarkNEXELIS
Filing DateSaturday, April 6, 2019
Status700 - REGISTERED
Status DateTuesday, October 26, 2021
Registration Number6540257
Registration DateTuesday, October 26, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 5, 2019

Trademark Statements

Goods and ServicesMedical, scientific and research laboratory services in preclinical and clinical immunology, immunogenicity, virology, bacteriology, immuno-oncology, biomarkers, vaccines, biologics, and immuno-therapeutics, immunochemistry assays, immunity assays, immunohistochemistry, histo-pathology, ligand binding assays, immuno-PCR, molecular assays, biomarkers, production of protein and immunologic reagents; conducting clinical trials for others

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 26, 2019
Primary Code042
First Use Anywhere DateMonday, September 23, 2019
First Use In Commerce DateMonday, September 23, 2019

Trademark Owner History

Party NameNEXELIS GROUP INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119
Party NameNEXELIS GROUP INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119
Party NameNexelis Group Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWilmington, DE 19801
Party NameNeomed Laboratory Topco Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWilmington, DE 19801

Trademark Events

Event DateEvent Description
Tuesday, October 26, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, September 21, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, September 20, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, September 20, 2021PREVIOUS ALLOWANCE COUNT WITHDRAWN
Thursday, September 9, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 9, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 9, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, April 15, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 15, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 15, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, March 11, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, March 11, 2021FINAL REFUSAL E-MAILED
Thursday, March 11, 2021SU - FINAL REFUSAL - WRITTEN
Wednesday, March 10, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, March 2, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 1, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 1, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, August 29, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, August 29, 2020NON-FINAL ACTION E-MAILED
Saturday, August 29, 2020SU - NON-FINAL ACTION - WRITTEN
Monday, August 24, 2020PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, August 18, 2020WITHDRAWN FROM ISSUE - OG REVIEW QUERY
Saturday, August 1, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, July 31, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, July 21, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, June 30, 2020USE AMENDMENT FILED
Tuesday, July 21, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 30, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, December 31, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 5, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 5, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 16, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 30, 2019ASSIGNED TO LIE
Tuesday, September 24, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 24, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, September 24, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 24, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, September 24, 2019EXAMINERS AMENDMENT -WRITTEN
Friday, September 6, 2019PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, July 16, 2019WITHDRAWN FROM PUB - OG REVIEW QUERY
Saturday, June 22, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 17, 2019ASSIGNED TO EXAMINER
Friday, April 26, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, April 10, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

nexelis assays immuno clinical biomarkers ligand pathology immunity immunohistochemistry histo binding